(Q42668582)

4 November 2017

title

An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. (English)

1 reference

4 November 2017

1 reference

1 reference

Meriggiola MC

1

1 reference

4 November 2017

Bremner WJ

2

1 reference

4 November 2017

Costantino A

3

1 reference

4 November 2017

Pavani A

4

1 reference

4 November 2017

Capelli M

5

1 reference

4 November 2017

Flamigni C

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

4 November 2017

published in

Fertility and Sterility

1 reference

4 November 2017

volume

68

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

844-850

1 reference

Prospects for new hormonal male contraceptives.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Suppression of human spermatogenesis by testosterone implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Androgens in men--uses and abuses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Clinical trial with testosterone undecanoate for male fertility control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Contraceptive efficacy of testosterone-induced azoospermia in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900363-4

10.1016/S0015-0282(97)00363-4

7 January 2021

Identifiers

DOI

1 reference

4 November 2017

1 reference